Knowledge Center

Article / Jan 01, 2011

What is Special About Inhalation APIs?

Authors:
  • Carla Vozone
Source:
Drug Development and Delivery, January 2011

What is Special About Inhalation APIs? Drug Development Executive: Carla Vozone, Director of Business Development for Hovione's Generics Business Unit, discusses what makes Hovione unique in API supply for inhalation, its supportive technologies, and approach to the market.

Related links

Read article here

Also in the Knowledge Center

Related Content

Privacy Notice – Cookies & Website/Application Data

This Privacy Notice – Cookies & Website/Application Data explains how Hovione collects and uses data through cookies and similar technologies on our website and applications.

Page
Read more

Drug Product Development

Leveraging our expertise particle engineering, Hovione can now develop oral dosage forms and inhaled dosages forms to offer dependable solutions for complex drug products.

Page
Read more

Hovione and Microinnova partner to advance modular flow chemistry for multi-purpose manufacturing

Press Release / Sep 24, 2025
Article
View